首页> 外国专利> Topical Formulation Composed of Cell Permeable Vascular Endothelial Growth Factor LMWP-VEGF fusion protein with Skin Physiological Activity

Topical Formulation Composed of Cell Permeable Vascular Endothelial Growth Factor LMWP-VEGF fusion protein with Skin Physiological Activity

机译:具有皮肤生理活性的细胞渗透性血管内皮生长因子LMWP-VEGF融合蛋白的局部制剂

摘要

The present invention relates to a composition for external application for skin containing a cell-permeable vascular endothelial cell growth factor fusion protein, and a cell external composition for cell-permeable cell permeation-containing vascular endothelial cell growth factor fusion protein is non-toxic to skin cells. Since the bio-active material contained in the protein has excellent cell permeability, it can be particularly effectively used for skin improvement (recovery), anti-aging or wound healing. In addition, the cell-permeable vascular endothelial cell growth factor fusion protein according to the present invention further comprises 1,2-hexanediol (Hexanediol), thereby exhibiting a remarkable synergistic effect in promoting collagen production, further anti-aging or wound healing. Can be used effectively.
机译:皮肤外用组合物技术领域本发明涉及一种含有细胞渗透性血管内皮细胞生长因子融合蛋白的皮肤外用组合物,并且该细胞外用组合物含有对细胞无毒的血管内皮细胞生长因子融合蛋白。皮肤细胞。由于蛋白质中包含的生物活性物质具有出色的细胞渗透性,因此可以特别有效地用于皮肤改善(恢复),抗衰老或伤口愈合。另外,根据本发明的细胞可渗透的血管内皮细胞生长因子融合蛋白还包含1,2-己二醇(己二醇),从而在促进胶原蛋白产生,进一步的抗衰老或伤口愈合方面显示出显着的协同作用。可以有效使用。

著录项

  • 公开/公告号KR102114845B1

    专利类型

  • 公开/公告日2020-05-27

    原文格式PDF

  • 申请/专利权人 주식회사 바이오에프디엔씨;

    申请/专利号KR20170120420

  • 发明设计人 정대현;김수정;박진우;

    申请日2017-09-19

  • 分类号A61K8/64;A61K38/18;A61Q19;A61Q19/08;

  • 国家 KR

  • 入库时间 2022-08-21 11:04:37

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号